Lam Research (NASDAQ:LRCX) Releases Q2 2025 Earnings Guidance

Lam Research (NASDAQ:LRCX) updated its second quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.770-0.970 for the period, compared to the consensus earnings per share estimate of 0.840. The company issued revenue guidance of $4.0 billion-$4.6 billion, compared to the consensus revenue estimate of $4.2 billion. Lam Research also updated its Q2 guidance to $0.77-0.97 EPS.

Lam Research Stock Up 5.1 %

LRCX stock traded up $3.71 during trading hours on Thursday, reaching $76.57. 23,182,076 shares of the stock were exchanged, compared to its average volume of 11,275,563. The company has a market cap of $10.01 billion, a price-to-earnings ratio of 2.82, a PEG ratio of 1.75 and a beta of 1.47. The firm’s 50-day moving average is $79.60 and its 200-day moving average is $89.94. Lam Research has a 12 month low of $57.44 and a 12 month high of $113.00. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.97 and a quick ratio of 2.00.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.05. Lam Research had a return on equity of 48.71% and a net margin of 25.68%. The business had revenue of $4.17 billion for the quarter, compared to analyst estimates of $4.06 billion. During the same quarter last year, the firm earned $6.85 EPS. Lam Research’s revenue for the quarter was up 19.7% compared to the same quarter last year. On average, equities research analysts expect that Lam Research will post 3.52 earnings per share for the current year.

Lam Research Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Investors of record on Tuesday, September 17th were given a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date was Tuesday, September 17th. Lam Research’s dividend payout ratio (DPR) is currently 3.38%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on LRCX shares. Wells Fargo & Company decreased their price objective on Lam Research from $88.00 to $85.00 and set an “equal weight” rating for the company in a report on Thursday. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $100.00 price target on shares of Lam Research in a research report on Thursday. Morgan Stanley cut their price objective on Lam Research from $81.00 to $77.00 and set an “equal weight” rating for the company in a report on Wednesday. UBS Group lowered their target price on shares of Lam Research from $125.00 to $115.00 and set a “buy” rating on the stock in a report on Thursday, September 12th. Finally, StockNews.com cut shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Friday, October 11th. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $97.03.

Insider Buying and Selling at Lam Research

In other news, CAO Christina Correia sold 647 shares of the business’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total transaction of $528,928.97. Following the completion of the transaction, the chief accounting officer now owns 4,267 shares of the company’s stock, valued at approximately $3,488,315.17. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.32% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.